Status:

UNKNOWN

CO(Mbined Therapy of Malignant) S(Alivary Gland tu)M(Ours With)I(MRT and) c(Arbon Ions): COSMIC

Lead Sponsor:

Heidelberg University

Conditions:

Malignancy

Salivary Glands

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

The COSMIC trial is a prospective, mono-centric, phase II trial evaluating toxicity and efficacy in the combined treatment with intensity-modulated radiation therapy (IMRT) and carbon ion (C12) boost....

Detailed Description

Local control in malignant salivary gland tumours is dose dependent. High local control rates in adenoid cystic carcinomas could be achieved by highly conformal radiotherapy techniques and particle (n...

Eligibility Criteria

Inclusion

  • Histologically confirmed or surgically removed malignant tumour of the salivary glands (head and neck)
  • Inoperable tumour
  • G2/3
  • Macroscopic or microscopic residual tumour (R2/ R1) or
  • ≥T3/T4 or
  • perineural invasion (Pn+)
  • written informed consent
  • pts aged 18 - 80 years
  • effective contraception for pts in childbearing age (\<12 months post beginning of menopause)

Exclusion

  • Prior radio- or chemotherapy for tumours of the head and neck
  • Other previous malignancy within the past 5 years except prior, adequately treated basal cell carcinoma of the skin or pre-invasive carcinoma of the cervix
  • Significant neurological or psychiatric condition including dementia or seizures or other serious medical condition prohibiting the patient's participation in the trial by judgement of the investigators
  • Legal incapacity or limited legal capacity
  • Positive serum/ urine beta-HCG/ pregnancy
  • Drug abuse

Key Trial Info

Start Date :

June 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

September 1 2013

Estimated Enrollment :

54 Patients enrolled

Trial Details

Trial ID

NCT01154270

Start Date

June 1 2010

End Date

September 1 2013

Last Update

April 24 2013

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Dept. of Radiation Oncology, INF 400

Heidelberg, Germany, 69120